Mechanistically, we identified negative feedback on RAF dimers in NRAS mutant melanoma as the likely culprit behind their lower sensitivity to single-agent MEK inhibition and synergistic response to panRAF co-inhibition. The gene discussed is NRAS; the disease is melanoma.